Re-emergence of Babesia conradae and effective treatment of infected dogs with atovaquone and azithromycin
Cicco, M. F. D., Downey, M. E., Beeler, E., Marr, H., Cyrog, P., Kidd, L., … Birkenheuer, A. J. (2012, January 9). Veterinary Parasitology, Vol. 187, pp. 23–27.
author keywords: Protozoal; Babesiosis; Piroplasm; Babesia gibsoni
MeSH headings : Animals; Antiprotozoal Agents / administration & dosage; Antiprotozoal Agents / therapeutic use; Atovaquone / administration & dosage; Atovaquone / therapeutic use; Azithromycin / administration & dosage; Azithromycin / therapeutic use; Babesia / classification; Babesiosis / drug therapy; Babesiosis / epidemiology; Babesiosis / parasitology; Babesiosis / veterinary; California / epidemiology; Communicable Diseases, Emerging / epidemiology; Communicable Diseases, Emerging / parasitology; Communicable Diseases, Emerging / veterinary; Dog Diseases / drug therapy; Dog Diseases / epidemiology; Dog Diseases / genetics; Dog Diseases / parasitology; Dogs; Female; Male; Pedigree
topics (OpenAlex): Vector-borne infectious diseases; Insect and Pesticide Research; Vector-Borne Animal Diseases
TL;DR:
Combination therapy with atovaquone and azithromycin appears to be effective for acute and chronic babesiosis caused by B. conradae.
(via
Semantic Scholar)
UN Sustainable Development Goal Categories
Sources: Web Of Science, ORCID, NC State University Libraries